TELO

About Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock

Telomir Pharmaceuticals, Inc. Common Stock (TELO) closed the 2026-09-18 session at $1.23, up 9.82% versus the previous close (+0.11). The stock opened at $1.15 and traded between $1.13 and $1.30 during that session. Session trading volume was 482K shares. The volume-weighted average price (VWAP) is $1.22.

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Telomir Pharmaceuticals, Inc. Common Stock has a market capitalization of $77.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TELO is listed on the XNAS exchange. The company employs approximately 5 people. Telomir Pharmaceuticals, Inc. Common Stock is headquartered in MIAMI, FL. The recorded listing date is 2024-02-09.

On this page you can find market TELO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.